Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.6% in the afternoon session after the major indices pulled back (Nasdaq -0.8%, S&P 500 -0.77%), largely due to escalating concerns surrounding the July 9th deadline for new US tariffs, now amplified by specific announcements.
Shares of cosmetics company e.l.f. Beauty (NYSE:ELF)
fell 7.1% in the afternoon session after a significant institutional investor, Allspring Global Investments Holdings LLC, reported a massive reduction in its holdings.
Shares of cloud monitoring software company Datadog (NASDAQ:DDOG) jumped 14.2% in the afternoon session after reports the company will be added to the S&P 500 index.
Shares of health insurance provider Elevance Health (NYSE:EVH)
fell 9.9% in the afternoon session after peer, Centene pulled its full-year financial guidance, triggering a sector-wide sell-off.
Shares of rail transportation company Greenbrier (NYSE:GBX)
jumped 19% in the afternoon session after the company posted much stronger-than-expected results for its fiscal third quarter and raised its profitability guidance for the full year. The railcar manufacturer reported quarterly earnings of $1.86 per share, handily beating analyst estimates of 98 cents. Sales also beat by a decent margin. The company achieved an aggregate gross margin of 18%, marking the seventh consecutive quarter it has met or exceeded its mid-teens target. Buoyed by the strong performance, Greenbrier raised its full-year guidance for both gross margin and operating margin. The company also highlighted new railcar orders for 3,900 units, valued at over $500 million, and a robust backlog of 18,900 units worth $2.5 billion. Additionally, the board declared its 45th consecutive quarterly dividend and noted ongoing share repurchases.
Shares of iPhone and iPad maker Apple (NASDAQ:AAPL) jumped 2.6% in the morning session after Jefferies upgraded the stock following a report indicating strong iPhone sales.
Shares of healthcare insurance company Molina Healthcare (NYSE:MOH)
fell 20.8% in the afternoon session after a sector-wide sell-off as competitor Centene pulled its full-year financial guidance.
Shares of computer processor maker Intel (NASDAQ:INTC)
fell 5.1% in the morning session after reports emerged that the company was considering a significant shift away from its 18A chip-making process. The potential move away from marketing its 18A process to new foundry customers signaled a major pivot for the chipmaker. This technology, which has incurred billions in development costs, was intended to make Intel competitive with industry leader TSMC.
